Phreesia remains resilient, maintaining guidance and showing strong financial performance. Find out why I remain bullish on ...

BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion” or the "Company”) (Nasdaq: ACON, ACONW), a ...

Aclarion, Inc. (NASDAQ:ACON) experienced a dramatic decrease of 74.13% in its stock price. Elevai Labs, Inc. (ELAB) saw a substantial price drop of 42.63%. Sleep Number Corporation (SNBR) reported a ...

Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company specializing in chronic low back pain diagnosis, with a current market capitalization of $7.11 million, ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company specializing in chronic low back pain diagnosis, with a current market capitalization of $7.11 million ...

Aclarion, Inc., a medical laboratories services provider, announced the approval of key proposals by its shareholders during a Special Meeting held on Tuesday. The meeting, which was initially set for ...

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...

BROOMFIELD, Colo., March 03, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...

Aclarion shares are trading higher by 124% during Monday's session. The company announced it signed a commercial deal with Scripps Health. Next: Get access to a new market-moving chart every day ...